Clinical Trial Update: Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of temozolomide, thalidomide, and celecoxib after radiation therapy in newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CELEBREX (Celecoxib)
• Temodar (Temozolomide)
• Thalomid (thalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED